ADIPOQ and cancer: Even though not in cancer models, additional studies further support the functional p44/42 MAPK role in either AdipoR- or adiponectin-mediated effects (Koskinen et al., 2011; Zhang et al., 2011; Alvarez et al., 2012; Wang et al., 2020).